Effect of GMI With and Without NM on LE in Cancer Patients With CIPN
CIPN
Effect of Graded Motor Imagery With and Without Neural Mobilization on Lower Extremity in Cancer Patients With Chemotherapy-induced Peripheral Neuropathy
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this interventional study is to learn if graded motor imagery with or without added neural mobilization can treat chemotherapy induced nerve related symptoms in lower limbs of cancer patients. The main questions it aims to answer are: \- Does graded motor imagery yields any added effects in relieving nerve related symptoms due to chemotherapy in lower limbs of cancer patients to the effects of nerve mobilization? Researchers will compare the effects of graded motor imagery as a standalone therapy (Group A) to the effects of graded motor imagery with nerve mobilization (Group B) Participants will take treatment sessions according to their allocated group, two sessions per week for six weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2025
CompletedFirst Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 17, 2026
CompletedJuly 17, 2026
July 1, 2026
3 months
July 14, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LANSS
Leeds Assessment of Neuropathic Symptoms and Sign
Baseline, week 3 (mid-intervention), week 6 (post intervention)
Secondary Outcomes (2)
Romberg Test
Baseline, week 6 (post-intervention)
EORTC-QLQ-CIPN20
Baseline, week 6 (post-intervention)
Study Arms (2)
Group A - Graded Motor Imagery
EXPERIMENTALGraded motor imagery sessions were provided twice a week for six weeks. Each GMI phase lasted for two weeks.
Group B - Grade Motor Imagey with Neural Mobilization
ACTIVE COMPARATORGraded motor imagery with neural mobilization sessions were provided twice a week for six weeks.
Interventions
Graded motor imagery is a series of three steps. The first step, lateral recognition, includes graded left and right judgment exercises. The second step involves imagining the performance of movements and the third, and last step involves performing movements in front of a mirror.
Nerve mobilization allows movement between structures of nervous system and its surrounding areas. It is used to mobilize the nervous system and maintain equilibrium inside the nervous system as well as in structures present in its surroundings.
Eligibility Criteria
You may qualify if:
- Both male and female
- Age ranging from 31 to 65 years
- Diagnosed cancer patients (stage 1 to 3, cancer of any kind)
- Chemotherapy sessions (antineoplastic drugs) - at least 1 session
- Presence of glove and stocking peripheral neuropathy
- LANSS score greater than 12
- Agreed to give complete follow-up
You may not qualify if:
- Any co-morbid conditions that can cause peripheral neuropathy e.g. diabetes, chronic kidney failure
- Any trauma history that can cause peripheral neuropathic symptoms
- Pre-existing nerve entrapment syndromes
- Diagnosed stage 4 cancer patients
- Cancer patients taking palliative chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Faisalabad
Faisalābad, Punjab Province, 38000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 17, 2026
Study Start
March 1, 2025
Primary Completion
June 6, 2025
Study Completion
June 6, 2025
Last Updated
July 17, 2026
Record last verified: 2026-07